UBS Group’s CalciMedica CALC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Buy |
17,003
+16,783
| +7,629% | +$26.9K | ﹤0.01% | 6927 |
|
|
2025
Q1 | $421 | Sell |
220
-105
| -32% | -$201 | ﹤0.01% | 8467 |
|
|
2024
Q4 | $1.15K | Buy |
325
+310
| +2,067% | +$1.1K | ﹤0.01% | 8053 |
|
|
2024
Q3 | $66 | Hold |
15
| – | – | ﹤0.01% | 7989 |
|
|
2024
Q2 | $59 | Sell |
15
-1
| -6% | -$4 | ﹤0.01% | 8055 |
|
|
2024
Q1 | $66 | Buy |
16
+2
| +14% | +$8 | ﹤0.01% | 7719 |
|
|
2023
Q4 | $40 | Sell |
14
-422
| -97% | -$1.21K | ﹤0.01% | 7797 |
|
|
2023
Q3 | $1.16K | Buy |
436
+422
| +3,014% | +$1.12K | ﹤0.01% | 6924 |
|
|
2023
Q2 | $56 | Buy |
+14
| New | +$56 | ﹤0.01% | 7504 |
|
|
2023
Q1 | – | Sell |
-384
| Closed | -$2.69K | – | 8506 |
|
|
2022
Q4 | $2.69K | Buy |
384
+369
| +2,460% | +$2.58K | ﹤0.01% | 8439 |
|
|
2022
Q3 | $0 | Sell |
15
-1,127
| -99% | – | ﹤0.01% | 9234 |
|
|
2022
Q2 | $17K | Buy |
1,142
+610
| +115% | +$9.08K | ﹤0.01% | 6045 |
|
|
2022
Q1 | $9K | Buy |
532
+318
| +149% | +$5.38K | ﹤0.01% | 7477 |
|
|
2021
Q4 | $5K | Buy |
214
+199
| +1,327% | +$4.65K | ﹤0.01% | 8253 |
|
|
2021
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 7993 |
|
|
2021
Q2 | $1K | Sell |
15
-132
| -90% | -$8.8K | ﹤0.01% | 8014 |
|
|
2021
Q1 | $11K | Buy |
147
+54
| +58% | +$4.04K | ﹤0.01% | 6821 |
|
|
2020
Q4 | $38K | Buy |
93
+70
| +304% | +$28.6K | ﹤0.01% | 5420 |
|
|
2020
Q3 | $4K | Buy |
+23
| New | +$4K | ﹤0.01% | 6508 |
|